Your browser doesn't support javascript.
loading
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.
Cava, Claudia; Bertoli, Gloria; Colaprico, Antonio; Olsen, Catharina; Bontempi, Gianluca; Castiglioni, Isabella.
Affiliation
  • Cava C; Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, 20090, Milan, Segrate-Milan, Italy. claudia.cava@ibfm.cnr.it.
  • Bertoli G; Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, 20090, Milan, Segrate-Milan, Italy.
  • Colaprico A; Interuniversity Institute of Bioinformatics in Brussels (IB)2, 1050, Brussels, Belgium.
  • Olsen C; Machine Learning Group (MLG), Department d'Informatique, Universite libre de Bruxelles (ULB), 1050, Brussels, Belgium.
  • Bontempi G; Interuniversity Institute of Bioinformatics in Brussels (IB)2, 1050, Brussels, Belgium.
  • Castiglioni I; Machine Learning Group (MLG), Department d'Informatique, Universite libre de Bruxelles (ULB), 1050, Brussels, Belgium.
BMC Genomics ; 19(1): 25, 2018 01 06.
Article in En | MEDLINE | ID: mdl-29304754
ABSTRACT

BACKGROUND:

Modern high-throughput genomic technologies represent a comprehensive hallmark of molecular changes in pan-cancer studies. Although different cancer gene signatures have been revealed, the mechanism of tumourigenesis has yet to be completely understood. Pathways and networks are important tools to explain the role of genes in functional genomic studies. However, few methods consider the functional non-equal roles of genes in pathways and the complex gene-gene interactions in a network.

RESULTS:

We present a novel method in pan-cancer analysis that identifies de-regulated genes with a functional role by integrating pathway and network data. A pan-cancer analysis of 7158 tumour/normal samples from 16 cancer types identified 895 genes with a central role in pathways and de-regulated in cancer. Comparing our approach with 15 current tools that identify cancer driver genes, we found that 35.6% of the 895 genes identified by our method have been found as cancer driver genes with at least 2/15 tools. Finally, we applied a machine learning algorithm on 16 independent GEO cancer datasets to validate the diagnostic role of cancer driver genes for each cancer. We obtained a list of the top-ten cancer driver genes for each cancer considered in this study.

CONCLUSIONS:

Our analysis 1) confirmed that there are several known cancer driver genes in common among different types of cancer, 2) highlighted that cancer driver genes are able to regulate crucial pathways.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Biomarkers, Tumor / Genomics / Gene Regulatory Networks / Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2018 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Biomarkers, Tumor / Genomics / Gene Regulatory Networks / Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2018 Type: Article Affiliation country: Italy